Compare
Jin Medical International Ltd. vs Lifeward Ltd. vs LogicMark, Inc. vs Myomo, Inc.
| Latest fiscal year | Jin Medical International Ltd. ZJYL | Lifeward Ltd. LFWD | LogicMark, Inc. LGMK | Myomo, Inc. MYO |
|---|---|---|---|---|
| Year ended | 2025-09-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $20.69M | $22.03M | $11.43M | $40.93M |
| Revenue growth (YoY) | -12.0% | -14.1% | +15.4% | +25.7% |
| Gross margin | 29.2% | 38.2% | 66.8% | 65.7% |
| Operating margin | 2.9% | -89.3% | -69.1% | -35.2% |
| Net margin | 5.8% | -90.4% | -65.4% | -38.1% |
| Net income | $1.19M | -$19.91M | -$7.47M | -$15.57M |
| EPS (Diluted) | $0.01 | -$17.16 | -$13.06 | -$0.37 |
| Operating cash flow | $2.90M | -$16.83M | -$5.06M | -$14.51M |
| Free cash flow | -$3.73M | -$16.84M | -$5.13M | -$16.25M |
| Cash & equivalents | n/a | $2.17M | $3.57M | $14.13M |
| Total assets | $53.37M | $22.90M | $20.31M | $38.64M |
| Total liabilities | $23.80M | $14.49M | $2.22M | $27.23M |
| Shareholders' equity | $29.57M | $8.41M | $16.28M | $11.40M |
| Return on year-end equity | 4.0% | -236.8% | -45.9% | -136.6% |
| Shares outstanding | 156.55M | 1.52M | 906.1K | 38.47M |
Revenue, most recent five fiscal years
| Fiscal year | Jin Medical International Ltd. | Lifeward Ltd. | LogicMark, Inc. | Myomo, Inc. |
|---|---|---|---|---|
| Latest | $20.69M Ended 2025-09-30 | $22.03M Ended 2025-12-31 | $11.43M Ended 2025-12-31 | $40.93M Ended 2025-12-31 |
| 1 year earlier | $23.50M Ended 2024-09-30 | $25.66M Ended 2024-12-31 | $9.90M Ended 2024-12-31 | $32.55M Ended 2024-12-31 |
| 2 years earlier | $19.82M Ended 2023-09-30 | $13.85M Ended 2023-12-31 | $9.93M Ended 2023-12-31 | $19.24M Ended 2023-12-31 |
| 3 years earlier | $19.19M Ended 2022-09-30 | $5.51M Ended 2022-12-31 | $11.92M Ended 2022-12-31 | $15.56M Ended 2022-12-31 |
| 4 years earlier | $20.76M Ended 2021-09-30 | $5.97M Ended 2021-12-31 | $10.02M Ended 2021-12-31 | $13.86M Ended 2021-12-31 |